TITLE

Early Patterns of Gene Expression Correlate With the Humoral Immune Response to Influenza Vaccination in Humans

AUTHOR(S)
Bucasas, Kristine L.; Franco, Luis M.; Shaw, Chad A.; Bray, Molly S.; Wells, Janet M.; Niño, Diane; Arden, Nancy; Quarles, John M.; Couch, Robert B.; Belmont, John W.
PUB. DATE
April 2011
SOURCE
Journal of Infectious Diseases;Apr2011, Vol. 203 Issue 7, p921
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Annual vaccination is the primary means for preventing influenza. However, great interindividual variability exists in vaccine responses, the cellular events that take place in vivo after vaccination are poorly understood, and appropriate biomarkers for vaccine responsiveness have not been developed.Methods. We immunized a cohort of healthy male adults with a licensed trivalent influenza vaccine and performed a timed assessment of global gene expression before and after vaccination. We analyzed the relationship between gene expression patterns and the humoral immune response to vaccination.Results. Marked up regulation of expression of genes involved in interferon signaling, positive IL-6 regulation, and antigen processing and presentation, were detected within 24 hours of immunization. The late vaccine response showed a transcriptional pattern suggestive of increased protein biosynthesis and cellular proliferation. Integrative analyses revealed a 494-gene expression signature—including STAT1, CD74, and E2F2—which strongly correlates with the magnitude of the antibody response. High vaccine responder status correlates with increased early expression of interferon signaling and antigen processing and presentation genes.Conclusions. The results highlight the role of a systems biology approach in understanding the molecular events that take place in vivo after influenza vaccination and in the development of better predictors of vaccine responsiveness.
ACCESSION #
84597061

 

Related Articles

  • Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab. Tsuru, Tomomi; Terao, Kimio; Murakami, Miho; Matsutani, Takaji; Suzaki, Midori; Amamoto, Toshiaki; Nakashima, Hitoshi; Akiyama, Azusa; Nishimoto, Norihiro // Modern Rheumatology (Springer Science & Business Media B.V.);May2014, Vol. 24 Issue 3, p511 

    Objectives. To evaluate humoral immune response to influenza vaccine and polysaccharide pneumococcal vaccine in patients with rheumatoid arthritis (RA) or Castleman's disease (CD) during tocilizumab therapy. Methods. Thirty-eight patients (28 RA and 10 CD) receiving tocilizumab and 39 RA...

  • Publisher Correction: Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. Trieu, Mai-Chi; Zhou, Fan; Lartey, Sarah Larteley; Sridhar, Saranya; Mjaaland, Siri; Cox, Rebecca Jane // NPJ Vaccines;2018, Vol. 3 Issue 1, pN.PAG 

    In the original published version of this Article, the text for the Editorial Summary was mistakenly incorporated at the end of the abstract. The HTML and PDF versions of the paper have been corrected.

  • Parenteral Vaccination against Influenza Does Not Induce a Local Antigen-Specific Immune Response in the Nasal Mucosa. Brokstad, Karl Albert; Eriksson, Jens-Christian; Cox, Rebecca Jane; Tynning, Turid; Olofsson, Jan; Jonsson, Roland; Davidsson, Ake // Journal of Infectious Diseases;4/1/2002, Vol. 185 Issue 7, p878 

    The immune response in the nasal mucosa to influenza vaccination in 23 patients scheduled for tonsillectomy was studied. A statistically significant increase in influenza virus-specific serum and oral fluid antibodies was observed 7 days after vaccination. The numbers of influenza virus ...

  • Cellular Immune Response May Be Key to Universal Flu Vaccine. Hampton, Tracy // JAMA: Journal of the American Medical Association;10/30/2013, Vol. 310 Issue 17, p1785 

    The article focuses on a study that was conducted by researcher S. Sridhar and colleagues and published in the journal "Nature Medicine," which suggests development of a universal flu vaccine based on T-cell responses to protect from viruses that become resistant to antibody-mediated immunity.

  • Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal... Belshe, Robert B.; Gruber, William C.; Mendelman, Paul M.; Mehta, Harshvardhan B.; Mahmood, Kutubuddin; Reisinger, Keith; Treanor, John; Zangwill, Ken; Hayden, Frederick G.; Bernstein, David I.; Kotloff, Karen; King, James; Piedra, Pedro A.; Block, Stan L.; Yan, Lihan; Wolff, Mark // Journal of Infectious Diseases;3/1/2000, Vol. 181 Issue 3, p1133 

    Studies correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. Safety and efficacy against virus shedding; Correlation between the presence of either serum antibody or nasal wash immunoglobulin A and protection from infection by...

  • Systems biology of vaccination for seasonal influenza in humans. Nakaya, Helder I; Wrammert, Jens; Lee, Eva K; Racioppi, Luigi; Marie-Kunze, Stephanie; Haining, W Nicholas; Means, Anthony R; Kasturi, Sudhir P; Khan, Nooruddin; Li, Gui-Mei; McCausland, Megan; Kanchan, Vibhu; Kokko, Kenneth E; Li, Shuzhao; Elbein, Rivka; Mehta, Aneesh K; Aderem, Alan; Subbarao, Kanta; Ahmed, Rafi; Pulendran, Bali // Nature Immunology;Aug2011, Vol. 12 Issue 8, p786 

    Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine...

  • A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses. Wennier, Sonia T.; Brinkmann, Kay; Steinhäußer, Charlotte; Mayländer, Nicole; Mnich, Claudia; Wielert, Ursula; Dirmeier, Ulrike; Hausmann, Jürgen; Chaplin, Paul; Steigerwald, Robin // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Modified vaccinia virus Ankara (MVA) has been shown to be suitable for the generation of experimental vaccines against cancer and infectious diseases, eliciting strong humoral and cellular immune responses. In viral vectored vaccines, strong recombinant antigen expression and timing of...

  • System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination. Zimmermann, Michael T.; Oberg, Ann L.; Grill, Diane E.; Ovsyannikova, Inna G.; Haralambieva, Iana H.; Kennedy, Richard B.; Poland, Gregory A. // PLoS ONE;3/31/2016, Vol. 11 Issue 3, p1 

    Failure to achieve a protected state after influenza vaccination is poorly understood but occurs commonly among aged populations experiencing greater immunosenescence. In order to better understand immune response in the elderly, we studied epigenetic and transcriptomic profiles and humoral...

  • Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy. Mehling, Matthias; Fritz, Stefanie; Hafner, Patricia; Eichin, Dominik; Yonekawa, Tomomi; Klimkait, Thomas; Lindberg, Raija L. P.; Kappos, Ludwig; Hess, Christoph // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Background: Interferon-beta (IFNβ) regulates the expression of a complex set of pro- as well as anti-inflammatory genes. In cohorts of MS patients unstratified for therapeutic response to IFNβ, normal vaccine-specific immune responses have been observed. Data capturing antigen-specific...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics